BioCentury | Jan 8, 2021
Finance

Jan. 8 Quick Takes: Venture rounds for Abbisko, DiCE, Aulos, LifeMine, Mana, Theolytics and more

...purpose acquisition company GX Acquisition Corp. (Nasdaq: GXGX). A syndicate including Starr Insurance Companies, Dragasac Ltd. and Sorrento Therapeutics Inc....
BioCentury | Nov 25, 2020
Product Development

Data Byte: a snapshot of the clinical cutaneous T cell lymphoma pipeline

...Inc. miRagen Therapeutics Inc. CerRx Inc. Innate Pharma S.A. BioCryst Pharmaceuticals Inc. Johnson & Johnson 4SC AG Medivir AB Bioniz Therapeutics Inc. Codiak BioSciences Inc. Sorrento Therapeutics Inc. Trillium...
BioCentury | Aug 29, 2020
Deals

Data Bytes: Cryoport deals show continued interest in cell, gene therapy manufacturing and supply chain players

...gene therapy offerings, which include the Advanced Therapy Shipper product line. Amanda Micklus Spark Therapeutics Celgene Corp. Juno Therapeutics Inc. Sorrento Therapeutics Inc. SmartPharm...
BioCentury | Aug 20, 2020
Management Tracks

Shao out as Sorrento CFO; plus changes at Kronos, Rome and Alveo

...By Robin Sawka, BioCentury Staff Sorrento Therapeutics Inc. (NASDAQ:SRNE) terminated Jiong Shao as EVP and CFO. He is succeeded as...
...He is succeeded as CFO by Najjam Asghar, who is the company’s chief accounting officer. Sorrento...
...Technologies Inc. hired Julianne Averill as CFO. She was VP of finance at BlackThorn Therapeutics Inc. Robin Sawka Sorrento Therapeutics Inc. Kronos...
BioCentury | Aug 18, 2020
Product Development

SalivaDirect slots into growing matrix of resource-saving COVID-19 tests

...these technologies for that use. On July 29, Sorrento Therapeutics Inc....
BioCentury | Jul 7, 2020
Product Development

Data Bytes: COVID-19 pipeline growth continues to flatten

...and vaccines. The newest preclinical vaccines in the pipeline include the protein-based T-VIVA-19 vaccine from Sorrento Therapeutics Inc....
BioCentury | May 22, 2020
Product Development

May 21 Quick Takes: EC approves Zolgensma for SMA; plus Sunovion, Kadmon, Sorrento, tafasitamab, Zentalis’ new JV

...inhibitor Sorrento Therapeutics Inc. (NASDAQ:SRNE) entered a binding term sheet with ACEA Therapeutics Inc. that would give Sorrento...
...neuron 1 telomeric SMN2 - Survival of motor neuron 2 centromeric Robin Sawka, BioCentury Staff Kadmon Holdings Inc. Sorrento Therapeutics Inc. Novartis...
BioCentury | May 16, 2020
Product Development

A guide to COVID-19 preclinical vaccine modalities

...platforms that promote antigen uptake and presentation by endogenous APCs. A "decoy cell" vaccine from Sorrento Therapeutics Inc....
BioCentury | May 15, 2020
Translation in Brief

Passage’s mouse, dog data for Krabbe disease; plus a predictive model of COVID-19 mortality, Sorrento’s COVID-19 antibody candidate and more

...an area under the curve (AUC) of 95%. Sorrento spikes on data for anti-spike antibody Sorrento Therapeutics Inc....
...CRP - C-reactive protein Env - HIV env GALC - Galactosylceramidase LDH - Lactate dehydrogenase BioCentury Staff Sorrento Therapeutics Inc. NIH Duke...
BioCentury | Mar 26, 2020
Product Development

COVID-19 roundup: Grifols partners with BARDA, FDA on convalescent plasma; plus Vir, Sorrento, Ascletis, BMS and Ipsen

...on Wednesday a partnership with the U.S. government to develop the therapy. Meanwhile, Vir and Sorrento...
...a non-exclusive license to Xtend for COVID-19 mAbs. Financial terms were undisclosed. Sorrento’s COVID-19 vaccine Sorrento Therapeutics Inc....
...enzyme 2 (ACE2), the host protein that the spike binds to mediate viral cell invasion. Sorrento...
Items per page:
1 - 10 of 169
BioCentury | Jan 8, 2021
Finance

Jan. 8 Quick Takes: Venture rounds for Abbisko, DiCE, Aulos, LifeMine, Mana, Theolytics and more

...purpose acquisition company GX Acquisition Corp. (Nasdaq: GXGX). A syndicate including Starr Insurance Companies, Dragasac Ltd. and Sorrento Therapeutics Inc....
BioCentury | Nov 25, 2020
Product Development

Data Byte: a snapshot of the clinical cutaneous T cell lymphoma pipeline

...Inc. miRagen Therapeutics Inc. CerRx Inc. Innate Pharma S.A. BioCryst Pharmaceuticals Inc. Johnson & Johnson 4SC AG Medivir AB Bioniz Therapeutics Inc. Codiak BioSciences Inc. Sorrento Therapeutics Inc. Trillium...
BioCentury | Aug 29, 2020
Deals

Data Bytes: Cryoport deals show continued interest in cell, gene therapy manufacturing and supply chain players

...gene therapy offerings, which include the Advanced Therapy Shipper product line. Amanda Micklus Spark Therapeutics Celgene Corp. Juno Therapeutics Inc. Sorrento Therapeutics Inc. SmartPharm...
BioCentury | Aug 20, 2020
Management Tracks

Shao out as Sorrento CFO; plus changes at Kronos, Rome and Alveo

...By Robin Sawka, BioCentury Staff Sorrento Therapeutics Inc. (NASDAQ:SRNE) terminated Jiong Shao as EVP and CFO. He is succeeded as...
...He is succeeded as CFO by Najjam Asghar, who is the company’s chief accounting officer. Sorrento...
...Technologies Inc. hired Julianne Averill as CFO. She was VP of finance at BlackThorn Therapeutics Inc. Robin Sawka Sorrento Therapeutics Inc. Kronos...
BioCentury | Aug 18, 2020
Product Development

SalivaDirect slots into growing matrix of resource-saving COVID-19 tests

...these technologies for that use. On July 29, Sorrento Therapeutics Inc....
BioCentury | Jul 7, 2020
Product Development

Data Bytes: COVID-19 pipeline growth continues to flatten

...and vaccines. The newest preclinical vaccines in the pipeline include the protein-based T-VIVA-19 vaccine from Sorrento Therapeutics Inc....
BioCentury | May 22, 2020
Product Development

May 21 Quick Takes: EC approves Zolgensma for SMA; plus Sunovion, Kadmon, Sorrento, tafasitamab, Zentalis’ new JV

...inhibitor Sorrento Therapeutics Inc. (NASDAQ:SRNE) entered a binding term sheet with ACEA Therapeutics Inc. that would give Sorrento...
...neuron 1 telomeric SMN2 - Survival of motor neuron 2 centromeric Robin Sawka, BioCentury Staff Kadmon Holdings Inc. Sorrento Therapeutics Inc. Novartis...
BioCentury | May 16, 2020
Product Development

A guide to COVID-19 preclinical vaccine modalities

...platforms that promote antigen uptake and presentation by endogenous APCs. A "decoy cell" vaccine from Sorrento Therapeutics Inc....
BioCentury | May 15, 2020
Translation in Brief

Passage’s mouse, dog data for Krabbe disease; plus a predictive model of COVID-19 mortality, Sorrento’s COVID-19 antibody candidate and more

...an area under the curve (AUC) of 95%. Sorrento spikes on data for anti-spike antibody Sorrento Therapeutics Inc....
...CRP - C-reactive protein Env - HIV env GALC - Galactosylceramidase LDH - Lactate dehydrogenase BioCentury Staff Sorrento Therapeutics Inc. NIH Duke...
BioCentury | Mar 26, 2020
Product Development

COVID-19 roundup: Grifols partners with BARDA, FDA on convalescent plasma; plus Vir, Sorrento, Ascletis, BMS and Ipsen

...on Wednesday a partnership with the U.S. government to develop the therapy. Meanwhile, Vir and Sorrento...
...a non-exclusive license to Xtend for COVID-19 mAbs. Financial terms were undisclosed. Sorrento’s COVID-19 vaccine Sorrento Therapeutics Inc....
...enzyme 2 (ACE2), the host protein that the spike binds to mediate viral cell invasion. Sorrento...
Items per page:
1 - 10 of 169